Search results for: 'outsourcing ofstrive processing extend opportunities'

Singapore is facing a rapidly aging population just like Japan and China. This demographic shift has created a number of opportunities for the industry participants to provide products, training, and services to meet the needs of Singapores elderly and the healthcare institutions which support them. The increasing number of elderly citizens is exp...

More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...

05 Apr 2023  |  Asia Pacific  |  Market Outlook

Asia-Pacific Pharmaceutical Industry Outlook, 2023

Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry

Infographics

×

Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japan,...

This study carries Frost & Sullivan’s observation of bone mineral density solutions in select Asian Countries (Australia, South Korea, and China); the regulatory trends for the same have been covered, highlighting the following: • Product registration and regulatory approval process details in select Asian countries (such as the Therapeutic Goods A...

This research deliverable provides deep insights into the clinical development and outsourcing market in India. It also includes an overview of the Indian regulatory and R&D process briefing about the clinical trials registration process, trends in regional/local pharmaceutical and biotechnology development as well as the impact of those developmen...

This study provides a comprehensive analysis of the contract research and manufacturing services (CRAMS) segment in India by focusing on drug discovery to pre-clinical toxicology, Active Pharmaceutical Ingredient (API), Formulations and Injectables. The study is based on detailed primary research, and includes an evaluation of the market size as we...

With a population of 620 million, ASEAN represents approximately 8.6% of the global population. With a combined GDP of US$2.4 trillion in 2013, growing at an average annual rate of 5.6%, the region’s economic growth outpaces many other regional and global economies. Demand for healthcare services is expected to surge due to factors such as populati...

30 Apr 2020  |  Asia Pacific  |  Market Outlook

COVID-19—Implications for the Healthcare Industry, 2020

Winning Strategies and Key Opportunities that are Evolving During this Disruption

Infographics

×

A team of futurists, analysts, and consultants from the Global Transformational Health Research Team at Frost & Sullivan have come together to render a comprehensive analysis to predict the future of healthcare with COVID-19 disruption in perspective. This study provides actionable predictions and growth opportunities for major healthcare segments ...

This research deliverable provides detailed insights into the clinical development and outsourcing market of India. It also includes an overview of the Indian regulatory and R&D process briefing. It describes the Clinical trials scenario today at a therapeutic level of focus. Furthermore, it highlights the key trends, drivers, restraints and also t...